Diproteverine HCl

CAS No. 69373-88-2

Diproteverine HCl( —— )

Catalog No. M36266 CAS No. 69373-88-2

Diproteverine HCl is a novel calcium antagonist with antianginal properties, antispasmodic and vasoactive.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 409 Get Quote
10MG 604 Get Quote
25MG 908 Get Quote
50MG 1251 Get Quote
100MG 1647 Get Quote
500MG 3312 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Diproteverine HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Diproteverine HCl is a novel calcium antagonist with antianginal properties, antispasmodic and vasoactive.
  • Description
    Diproteverine HCl is a novel calcium antagonist with antianginal properties, antispasmodic and vasoactive.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    69373-88-2
  • Formula Weight
    462.02
  • Molecular Formula
    C26H36ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.N1=C(C=2C=C(OC(C)C)C(OC(C)C)=CC2CC1)CC3=CC=C(OCC)C(OCC)=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ziconotide

    Ziconotide is an atypical analgesic agent for the amelioration of severe and chronic pain. Derived from Conus magus, a cone snail, it is the synthetic form of an ω-conotoxin peptide.

  • Opc 8490

    Opc 8490 is a cardiotonic agent and a positive inotropic vasodilator that increases Ca current (ICa) in a dose-dependent and reversible manner and prolongs atrial action potential in a concentration-dependent manner.

  • CRAC intermediate 1

    CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.